Certified by Founder Lodge
GC Cell
Korea, Republic Of - Yongin-si, Gyeonggi-do
INVESTOR
1 Disclosed Funding Rounds $16,500,000
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
GC Cell has various pipelines based on NK, T, and stem cells. GC Cell has excellent research capabilities and global-level cell therapy products based on solid platform technology from initia
| Company | Date | Round | Raised |
|---|---|---|---|
 Feldan Therapeutics |
June, 14 ,2023 | Series B | $16,500,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
